One key opinion leader calls on healthcare to ensure access to gene therapies.
Cancer and Genetics
The growing availability of direct-to-consumer genetic tests highlights the need for validating and interpreting the tests’ results.
The technology is improving rapidly, becoming not only more accessible but much, much cheaper.
Cancer is one of the top deadliest diseases in the world and can be difficult to treat. We want to hear from you about your current challenges and what you think about future prospects in cancer therapy.
In this era of precision oncology and targeted therapies for cancer, it’s even more important to include different populations when doing clinical trials. Here are three effective strategies.
Gwen Nichols, MD, chief medical officer of the Leukemia & Lymphoma Society, offers a quick overview of current developments as well as a look forward.
New Cardinal Health Specialty Solutions research shares inside information about oncologists’ views about targeted therapies.